X-Vax Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Liquidation

X-Vax General Information

Description

Operator of a biotechnology company intended to develop vaccines against pathogens acquired by a mucosal infection. The company develops a herpes vaccine candidate which is based on an HSV-2 virus genetically deleted for glycoprotein D (gD-2) and is able to prevent infections caused by herpes type 1 (HSV-1) and type 2 (HSV-2) in multiple preclinical models, enabling medical practitioners to have a vaccine that induces Fc receptor activating antibodies that mediate antibody-dependent cell-mediated killing (ADCK) as the primary mechanism of protection.

Contact Information

Website
x-vax.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3507 Kyoto Gardens Drive
  • Suite 310
  • Palm Beach Gardens, FL 33410
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3507 Kyoto Gardens Drive
  • Suite 310
  • Palm Beach Gardens, FL 33410
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X-Vax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 22-Nov-2023 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Jul-2019 Completed Generating Revenue
To view X-Vax’s complete valuation and funding history, request access »

X-Vax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view X-Vax’s complete cap table history, request access »

X-Vax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X-Vax FAQs

  • When was X-Vax founded?

    X-Vax was founded in 2015.

  • Where is X-Vax headquartered?

    X-Vax is headquartered in Palm Beach Gardens, FL.

  • What is the size of X-Vax?

    X-Vax has 11 total employees.

  • What industry is X-Vax in?

    X-Vax’s primary industry is Drug Discovery.

  • Is X-Vax a private or public company?

    X-Vax is a Private company.

  • What is X-Vax’s current revenue?

    The current revenue for X-Vax is .

  • How much funding has X-Vax raised over time?

    X-Vax has raised $56.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process